The International Journal of Developmental Biology

Int. J. Dev. Biol. 43: 843 - 846 (1999)

Vol 43, Issue 8

Changes in the placenta and in the rat embryo caused by the demethylating agent 5-azacytidine

Published: 1 November 1999

M Vlahovic, F Bulic-Jakus, G Juric-Lekic, A Fucic, S Maric and D Serman

Department of Biology, Medical Faculty, Zagreb, Croatia. majav@mef.hr

Abstract

DNA methylation is an important mechanism for regulation of gene expression during vertebrate development. 5-azacytidine is used as an experimental tool for demethylation. In this work, a single dose of 5-azacytidine (5 mg/kg body weight) was administered to rats at different stages of development. After 5-azacytidine administration on the first or third day of pregnancy, no changes were detected. After administration on the fourth day of pregnancy or later, a reduction in growth was observed. After treatment on day five and on any other day till day eleven of pregnancy, no living fetuses were found. Of those treated on day twelve, 24% of fetuses survived, but forelimb and hindlimb malformations were present. Administered on day thirteen, 5-azacytidine did not interfere with survival, but malformations were still present. From day fourteen on, 5-azacytidine caused no gross external malformations. Placentas were also influenced by 5-azacytidine. They were significantly smaller and histological evaluation showed the labyrinthine part to be severely reduced. In contrast, trophoblast giant cells were more abundant than in controls.

Full text in web format is not available for this article. Please download the PDF version.